The last few weeks, I have written about the complex molecular immunity mechanism of CRISPR and how we can harness it to precisely edit genes in a gamut of cells. But the ability of CRISPR to treat genetic disorders, predispositions, and susceptibilities relies on our understanding of the genetic basis of disease. Since the completion of the Human Genome Project (HGP) in 2003, which sought to sequence the entire human genome, scientists have made great strides in connecting diseases and disorders with their genetic backgrounds. In the meantime, the invention of Next Generation Sequencing (NGS) in 2006 has drastically reduced…
Comments closed